BL-8040: Additional Phase IIa data

Data from 39 patients with relapsed or refractory AML in an open-label, U.S. and Israeli Phase

Read the full 165 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE